Angiopoietin-like Proteins
"Angiopoietin-like Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of proteins that is structurally similar to ANGIOPOIETINS but do not bind angiopoietin receptors. They are characterized by an amino-terminal coiled-coil domain, a linker region, and a carboxy-terminal FIBRINOGEN-like domain with the exception of ANGPTL8, which lacks the fibrinogen-like domain. They function in a variety of developmental and physiological processes, including INFLAMMATION, lipid metabolism, hematopoietic stem cell activity, and cancer metastasis.
| Descriptor ID |
D000075802
|
| MeSH Number(s) |
D12.644.276.100.050 D12.776.467.100.050 D23.529.100.050
|
| Concept/Terms |
Angiopoietin-like Proteins- Angiopoietin-like Proteins
- Angiopoietin like Proteins
- Angiopoietin-like Protein
- Angiopoietin like Protein
- Angiopoietin-related Protein
- Angiopoietin related Protein
|
Below are MeSH descriptors whose meaning is more general than "Angiopoietin-like Proteins".
Below are MeSH descriptors whose meaning is more specific than "Angiopoietin-like Proteins".
This graph shows the total number of publications written about "Angiopoietin-like Proteins" by people in this website by year, and whether "Angiopoietin-like Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
| 2017 | 3 | 1 | 4 |
| 2018 | 5 | 3 | 8 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Angiopoietin-like Proteins" by people in Profiles.
-
Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study. Eur J Prev Cardiol. 2020 12; 27(19):2251-2254.
-
Circulating betatrophin in relation to metabolic, inflammatory parameters, and oxidative stress in patients with type 2 diabetes mellitus. Diabetes Metab Syndr. 2019 Jan - Feb; 13(1):458-463.
-
Novel Therapeutic Targets for Managing Dyslipidemia. Trends Pharmacol Sci. 2018 08; 39(8):733-747.
-
Angptl2 deficiency attenuates paraquat (PQ)-induced lung injury in mice by altering inflammation, oxidative stress and fibrosis through NF-?B pathway. Biochem Biophys Res Commun. 2018 09 03; 503(1):94-101.
-
Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes. Cardiovasc Diabetol. 2018 06 08; 17(1):81.
-
Molecular aspects of hypercholesterolemia treatment: current perspectives and hopes. Ann Med. 2018 06; 50(4):303-311.
-
Angiopoietin-like 3 Is a Potential Biomarker for Retinopathy in Type 2 Diabetic Patients. Am J Ophthalmol. 2018 07; 191:34-41.
-
Increased plasma and adipose tissue levels of ANGPTL8/Betatrophin and ANGPTL4 in people with hypertension. Lipids Health Dis. 2018 Mar 01; 17(1):35.
-
Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation. Curr Pharm Des. 2018; 24(31):3638-3646.
-
Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT. BMC Infect Dis. 2017 09 29; 17(1):650.